Add-on pharmacotherapy for patients with first-episode schizophrenia: a clinical perspective
Eur J Clin Pharmacol
.
2021 Jun;77(6):931-932.
doi: 10.1007/s00228-020-02973-2.
Epub 2020 Jul 29.
Authors
Qin Xiang Ng
1
2
,
Joyce Wei Xin Chong
3
,
Kuan Tsee Chee
3
Affiliations
1
Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore, 539747, Singapore. ng.qin.xiang@u.nus.edu.
2
MOH Holdings Pte Ltd, 1 Maritime Square, Singapore, 099253, Singapore. ng.qin.xiang@u.nus.edu.
3
Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore, 539747, Singapore.
PMID:
32728915
DOI:
10.1007/s00228-020-02973-2
No abstract available
Publication types
Letter
MeSH terms
Antipsychotic Agents / therapeutic use*
Humans
Schizophrenia / drug therapy*
Substances
Antipsychotic Agents